Cargando…
Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia
Objective. The tyrosine kinase inhibitors have markedly changed the disease course for patients with Ph(+) and/or BCR-ABL1 (+) chronic myeloid leukemia (CML). This study was embarked upon to assess the long-term effects of imatinib therapy on survival in adult Nigerian patients with CML. Methods. Al...
Autores principales: | Oyekunle, Anthony A., Bolarinwa, Rahman A., Oyelese, Adesola T., Salawu, Lateef, Durosinmi, Muheez A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575984/ https://www.ncbi.nlm.nih.gov/pubmed/26435715 http://dx.doi.org/10.1155/2015/908708 |
Ejemplares similares
-
Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
por: Oyekunle, Anthony A., et al.
Publicado: (2016) -
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report
por: Ahmed, Ibrahim O., et al.
Publicado: (2021) -
Degrees of Kidney Disease in Nigerian Adults with Sickle-Cell Disease
por: Aneke, John C., et al.
Publicado: (2014) -
Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls
por: Bamgboje, Abayomi O, et al.
Publicado: (2022) -
AIDS-related lymphomas in Nigeria an emerging phenomenon
por: Salawu, L, et al.
Publicado: (2010)